Reteplase

瑞替普酶

Report date: 2026/05/25 20:02:40

Base Information

Drug NameReteplase
Drug Alias Name雷特普酶（罗氏）Reteplasum (Roche)Ecoplase (Roche)瑞特普酶 （罗氏）Reteplasa (Roche) +[12] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsIschemic StrokeMyocardial Infarction
Global Approved IndicationsMyocardial Infarction
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date1996/08/29
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEkr Therapeutics Inc
Inactive CompaniesZeenat Qureshi Stroke InstituteRoche Registration Ltd
Active IndicationsMyocardial Infarction
Inactive IndicationsIschemic Stroke

Other Information

ATC CodeB01AD07
Related LinksWikipediaDrugBankKEGG